{"id":"https://openalex.org/W156266284","doi":null,"title":"A comparison of the hemodynamic effects of urapidil, prazosin, and clonidine in healthy volunteers.","display_name":"A comparison of the hemodynamic effects of urapidil, prazosin, and clonidine in healthy volunteers.","publication_year":1994,"publication_date":"1994-01-01","ids":{"openalex":"https://openalex.org/W156266284","mag":"156266284","pmid":"https://pubmed.ncbi.nlm.nih.gov/7804515"},"language":"en","primary_location":{"id":"pmid:7804515","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7804515","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood pressure. Supplement","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032986176","display_name":"Nicholas D Moore","orcid":"https://orcid.org/0000-0003-1212-2817","observed_orcids":["https://orcid.org/0000-0003-1212-2817"]},"institutions":[{"id":"https://openalex.org/I4210154623","display_name":"Centre Hospitalier Universitaire de Rouen","ror":"https://ror.org/04cdk4t75","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210154623"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N Moore","raw_affiliation_strings":["VACOMED, Service de Pharmacologie Clinique, CHU Rouen, Boisguillaume, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VACOMED, Service de Pharmacologie Clinique, CHU Rouen, Boisguillaume, France","institution_ids":["https://openalex.org/I4210154623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043261536","display_name":"J Fresel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Fresel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058152753","display_name":"Robinson Joannid\u00e8s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Joannid\u00e8s","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109168224","display_name":"Patricia Compagnon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Compagnon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111841340","display_name":"Christian Thuillez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Thuillez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.01545807,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"4","issue":null,"first_page":"7","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10745","display_name":"Heart Rate Variability and Autonomic Control","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11950","display_name":"Cardiovascular Syncope and Autonomic Disorders","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urapidil","display_name":"urapidil","score":1.0},{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":1.0},{"id":"https://openalex.org/keywords/clonidine","display_name":"clonidine","score":1.0},{"id":"https://openalex.org/keywords/hemodynamic-effects","display_name":"hemodynamic effects","score":0.8579999804496765},{"id":"https://openalex.org/keywords/alpha-1-adrenergic-blockade","display_name":"alpha-1 adrenergic blockade","score":0.7889999747276306},{"id":"https://openalex.org/keywords/5-ht1a-receptor-agonism","display_name":"5-HT1A receptor agonism","score":0.906000018119812},{"id":"https://openalex.org/keywords/submaximal-exercise","display_name":"submaximal exercise","score":0.7710000276565552},{"id":"https://openalex.org/keywords/systemic-vascular-resistance-index","display_name":"systemic vascular resistance index","score":0.6850000023841858},{"id":"https://openalex.org/keywords/plasma-norepinephrine","display_name":"plasma norepinephrine","score":0.8650000095367432},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.9620000123977661},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7860000133514404},{"id":"https://openalex.org/keywords/sympathetic-inhibition","display_name":"sympathoinhibition","score":0.781000018119812},{"id":"https://openalex.org/keywords/parasympathetic-activation","display_name":"parasympathetic activation","score":0.8209999799728394},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.902999997138977}],"concepts":[{"id":"https://openalex.org/C2778040405","wikidata":"https://www.wikidata.org/wiki/Q418922","display_name":"Urapidil","level":4,"score":0.9604766368865967},{"id":"https://openalex.org/C2780648677","wikidata":"https://www.wikidata.org/wiki/Q425296","display_name":"Prazosin","level":4,"score":0.8846038579940796},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.618426501750946},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.6110259294509888},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5672159194946289},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.5627167820930481},{"id":"https://openalex.org/C178853913","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Hemodynamics","level":2,"score":0.5260027647018433},{"id":"https://openalex.org/C58245268","wikidata":"https://www.wikidata.org/wiki/Q456026","display_name":"Vascular resistance","level":3,"score":0.5161674618721008},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4306797385215759},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41149741411209106},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.4112722873687744},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.13785788416862488},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.052134543657302856},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003000","descriptor_name":"Clonidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014655","descriptor_name":"Vascular Resistance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:7804515","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7804515","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood pressure. Supplement","raw_type":"Clinical Trial"},{"id":"mag:156266284","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7804515","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1968226995","https://openalex.org/W2011918718","https://openalex.org/W2066464466","https://openalex.org/W2011900446","https://openalex.org/W2409022162","https://openalex.org/W2075184895","https://openalex.org/W2509524671","https://openalex.org/W1979202826","https://openalex.org/W2013468535","https://openalex.org/W2989046821"],"abstract_inverted_index":{"Urapidil":[0],"is":[1,194,220],"an":[2],"antihypertensive":[3],"agent":[4],"known":[5],"to":[6,14,114],"have":[7,186],"central":[8],"5HT1A":[9],"agonistic":[10],"properties":[11],"in":[12,66,72,122,128,142,148,169],"addition":[13],"alpha-1":[15],"blocking":[16],"effects.":[17],"To":[18],"assess":[19],"the":[20,27,191,197,215],"importance":[21],"of":[22,30,35,42,212,218,225],"these":[23],"effects,":[24,189],"we":[25],"compared":[26,113],"hemodynamic":[28],"effects":[29],"a":[31,67,125,149,208],"single":[32],"oral":[33],"dose":[34],"urapidil":[36,116,131,183,202,219],"(U,":[37],"60":[38],"mg)":[39],"with":[40,124,166],"those":[41],"prazosin":[43,118,134,185],"(Pr,":[44],"2":[45],"mg),":[46,50],"clonidine":[47,154],"(Cl,":[48],"0.15":[49],"and":[51,59,95,109,117,138,161,180,184,196],"placebo":[52],"(Pl),":[53],"at":[54,176],"rest,":[55,106,177],"during":[56,60,107,110,178,181],"orthostatic":[57],"tilt,":[58,108],"submaximal":[61],"graded":[62],"bicycle":[63],"exercise":[64],"tests,":[65],"double-blind":[68],"randomised":[69],"crossover":[70],"study":[71],"24":[73],"healthy":[74],"male":[75],"volunteers.":[76],"The":[77],"variables":[78],"studied":[79],"were":[80,103],"heart":[81,170],"rate,":[82],"mean":[83],"blood":[84,156],"pressure,":[85],"cardiac":[86],"index":[87,93],"by":[88],"bioimpedance,":[89],"systemic":[90],"vascular":[91],"resistance":[92],"(SVRI),":[94],"plasma":[96],"norepinephrine.":[97],"Baseline":[98],"values":[99],"before":[100],"drug":[101],"administration":[102],"identical.":[104],"At":[105],"identical":[111],"exercise,":[112,182],"placebo,":[115],"caused":[119],"similar":[120,150,187],"decreases":[121],"SVRI,":[123],"smaller":[126],"increase":[127],"HR":[129],"after":[130,133,201,204],"than":[132,203,223],"(p":[135,158,163],"<":[136,159,164],"0.01),":[137],"without":[139],"any":[140],"difference":[141,168],"BP.":[143],"Both":[144],"drugs":[145],"increased":[146],"norepinephrine":[147,162],"manner.":[151],"In":[152,174],"contrast,":[153],"decreased":[155],"pressure":[157],"0.01)":[160,165],"no":[167],"rate":[171],"or":[172],"SVRI.":[173],"conclusion,":[175],"tilt":[179],"vasodilating":[188],"but":[190],"sympathetic":[192],"stimulation":[193,199],"less":[195,221],"parasympathetic":[198],"greater":[200],"prazosin,":[205],"probably":[206],"indicating":[207],"centrally":[209],"acting":[210],"effect":[211,217],"urapidil.":[213],"However,":[214],"sympathoinhibitory":[216],"marked":[222],"that":[224],"clonidine.":[226]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}